Group Lifestyle Balance Adapted for Individuals With Impaired Mobility

Status Completed

Clinical Trial Summary

This study tested the effectiveness of the Group Lifestyle Balance™ (GLB) program adapted specifically for people with impaired mobility using standard behavioral approaches for weight loss. The overarching aim of this study was to promote health and reduce chronic disease risk among people with mobility impairment by building an evidence base for weight loss. The central hypothesis was that participants randomized to the intervention arm of the adapted GLB would show significant improvements on primary outcomes of weight and PA compared to a 6-month wait-list control group at 3 and 6 months, and show improvements on several secondary health outcomes.

Clinical Trial Description

The following are the specific study aims and hypotheses:

Aim 1: To create an appropriate and usable adaptation of the GLB program for people with mobility impairment.

Hypothesis 1.1: Advisory board participants will identify key adaptations to make the GLB materials appropriate and usable for individuals with impaired mobility.

Aim 2: To establish whether the adapted GLB program for people with mobility impairment is a feasible intervention.

Hypothesis 2.1: Intervention participants will rate the program satisfactorily and attend at least 2/3rd of the weekly group-based meetings and monthly individualized phone calls. Lifestyle coaches will also rate the adapted program satisfactorily.

Aim 3: To determine if the GLB intervention adapted for those with mobility impairment is effective as determined by significant improvement in the primary and secondary outcomes in the intervention group compared to the wait-list control group at 3 and 6 months from baseline.

Hypothesis 3.1: The intervention group will demonstrate significantly greater improvements in our primary outcomes (weight and PA) than the wait list control group at 3 and at 6 months and will show significant improvements in secondary outcomes at 6 months. Hypothesis 3.2: Both groups combined will demonstrate significantly greater improvements in the primary outcomes (weight and PA) after 3, 6 and 12 months of intervention and secondary outcomes after 6 and 12 months of intervention. ;

Study Design

Related Conditions & MeSH terms

Mobility Limitation

Clinical Trial Details

NCT number	NCT03307187
Study type	Interventional
Source	Baylor Research Institute
Contact
Status	Completed
Phase	N/A
Start date	May 2015
Completion date	February 2017

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06396247` - Impact of Brief Daily Functional Resistance Training on Lower Extremity Physical Performance	Phase 2/Phase 3
Not yet recruiting	`NCT05975476` - Comparison of Two Park-Based Activities on Emotional Well-Being in Adults With Mobility Impairments	N/A
Completed	`NCT01647802` - Cross-over Study of Three Modular Devices for Aid in Patient Standing and Transfer	N/A
Completed	`NCT01614392` - Lower Extremity Muscle and Function in the Elderly: Study 2	N/A
Enrolling by invitation	`NCT05736484` - Randomized Clinical Trial to Improve Mobility After Hospitalization	N/A
Active, not recruiting	`NCT05678985` - Evaluating Impact and Implementation of Choose to Move (Phase 4)	N/A
Completed	`NCT06025656` - Assessment of the Reliability and Validity of the Leg Lateral Reach Test in Adolescent Tennis Players	N/A
Completed	`NCT04760392` - Goal-directed Mobilization of Medical Inpatients	N/A
Enrolling by invitation	`NCT06434298` - Provincial Scale-up of Choose to Move (CTM) Phase 4	N/A
Recruiting	`NCT05516030` - HIFT for People With Mobility-Related Disabilities	N/A
Not yet recruiting	`NCT06264362` - Developing a Nonpharmacological Pain Intervention for Community-dwelling Older Adults With Dementia	N/A
Withdrawn	`NCT04044846` - Promoting Movement in Older Adults in the Community	N/A
Terminated	`NCT03558841` - Effect of Lyra Gait Training on the Mobility of Geriatric Rehabilitation Inpatients	N/A
Not yet recruiting	`NCT03675490` - ABLE (Arts-Based Exercise Enhancing LongEvity)	N/A
Completed	`NCT02913963` - Changes on Pain and Range of Motion by the Use of Kinesio Taping in Subjects With Myofascial Trigger Point	N/A
Completed	`NCT02913976` - Changes on Pain and Range of Motion by the Use of Kinesio Taping in Patients Diagnosed With Cervical Pain	N/A
Completed	`NCT05081856` - Use Modular Medical Equipment Vehicle in Mobilization of Patient With Chest Tube	N/A
Completed	`NCT02498704` - Dry Needling and Stretching vs. Stretching Alone on Hamstring Flexibility in Patients With Knee Pain	N/A
Withdrawn	`NCT02298374` - Evaluation of Homecare Reablement, the Trondheim Model	N/A
Completed	`NCT00177359` - Restoring Skill in Walking	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Group Lifestyle Balance Adapted for Individuals With Impaired Mobility (GLB-AIM) — GLB-AIM

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms